Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?

Answer from: at Academic Institution

The answer to this question will need to be case-by-case, unfortunately.The short answer:The priority in this patient case for using Sotalol is likely the underlying heart disease and its associated arrhythmia, and this cardiac benefit would not be achieved by Carvedilol and other NSBBs. Thus, it wo...

Please select the option that best describes you:

Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?

Related Questions